- Toshiba to Briefly Halt Chip Output on Weak Demand
- Boeing Mulls Pushing Back Dreamliner Deliveries
- Chief Executive Quits Australian Publisher Fairfax
- Asian Markets Wobble on Gloomy Economic Outlook
- Motor Racing-Honda Pulls Out of Formula One
- Job Cuts Picking Up Steam Just in Time for Holidays
- Pros Say: Bear Market Rallies = New Reality
- CEOs Sound Off: Budget Deficit, Bailouts & More
- Bernanke: 'More Needs To Be Done' on Foreclosures
- Wall of Shame: Fortress Investment's Wes Edens
- Cramer to Geithner: Let FDIC Chair Keep Her Job
- Lightning Round: Boeing, Medtronic, Agrium and More
- Lightning Round OT: Continental, Amylin Pharma and More
- Sell Block: Cramer's Solution for Mortgage-Backed Paper Mess
- Toll Brothers CEO's Housing Outlook
- Making Money Off M&A
- Your First Move For Friday December 5th
- Web Extra: Fast & Furious Trades For Friday
- ADB lends $500 mln to clean up dirtiest river
- Tough economy forces many US Muslims delay hajj
- Mexico wants to shrink coins to save a few cents
- Mexican Senate passes stricter credit rules
- US, China promise $20 billion to finance trade
- Cemex: World Bank unit to hear Venezuela dispute
- Philippines' inflation eases for 3rd month
- Report: Boeing may further postpone 787 deliveries
- CEO of Australia's Fairfax Media resigns
- Q&A with General Motors CEO Rick Wagoner
Final Glance: Medical Devices companies
NEW YORK - Shares of some top medical devices companies were mixed at the close of trading:
Abbott Labs fell $1.12 or 2.1 percent, to $52.03.
Allergan rose $.22 or .6 percent, to $36.42.
Bard fell $1.83 or 2.2 percent, to $82.09.
Baxter fell $1.58 or 2.9 percent, to $52.10.
Boston Scientific fell $.34 or 4.9 percent, to $6.57.
Hospira fell $1.66 or 5.7 percent, to $27.34.
Johnson & Johnson fell $1.14 or 2.0 percent, to $56.18.
Medtronic rose $.16 or .5 percent, to $30.45.
St Jude Medical fell $.54 or 1.8 percent, to $29.62.
Stryker fell $.81 or 2.1 percent, to $36.88.
Zimmer rose $.34 or .9 percent, to $37.11.
Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Tools:



